Analysts See $0.12 EPS for Tabula Rasa Healthcare, Inc. (TRHC)

February 12, 2018 - By Migdalia James

 Analysts See $0.12 EPS for Tabula Rasa Healthcare, Inc. (TRHC)

Analysts expect Tabula Rasa Healthcare, Inc. (NASDAQ:TRHC) to report $0.12 EPS on March, 12.They anticipate $0.18 EPS change or 300.00 % from last quarter’s $-0.06 EPS. TRHC’s profit would be $2.30 million giving it 71.81 P/E if the $0.12 EPS is correct. After having $0.02 EPS previously, Tabula Rasa Healthcare, Inc.’s analysts see 500.00 % EPS growth. The stock increased 5.19% or $1.7 during the last trading session, reaching $34.47. About 165,957 shares traded. Tabula Rasa Healthcare, Inc. (NASDAQ:TRHC) has 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.

Tabula Rasa Healthcare, Inc. (NASDAQ:TRHC) Ratings Coverage

Among 3 analysts covering Tabula Rasa HealthCare (NASDAQ:TRHC), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Tabula Rasa HealthCare had 3 analyst reports since October 24, 2016 according to SRatingsIntel. UBS initiated Tabula Rasa Healthcare, Inc. (NASDAQ:TRHC) rating on Monday, October 24. UBS has “Buy” rating and $18 target. The company was initiated on Monday, October 24 by Wells Fargo. The firm has “Overweight” rating given on Monday, October 24 by Piper Jaffray.

Tabula Rasa HealthCare, Inc. provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to enhance patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. The company has market cap of $661.20 million. The Company’s cloud software applications include EireneRx, which is used by at-risk healthcare organizations to access its patients' medication-related information; MedWise Advisor that allows for components of EireneRx to be used independently and by a broader healthcare audience; and NiaRx, an educational software platform used in the pharmacy educational community. It currently has negative earnings. The firm offers its technology-enabled services and products for medication risk management and risk adjustment.

More notable recent Tabula Rasa Healthcare, Inc. (NASDAQ:TRHC) news were published by: Marketwatch.com which released: “Tabula Rasa HealthCare Inc.” on October 24, 2016, also Globenewswire.com with their article: “Tabula Rasa HealthCare and Landmark to Improve Patient Outcomes in California …” published on May 01, 2017, Seekingalpha.com published: “Tabula Rasa HealthCare’s (TRHC) CEO Calvin Knowlton on Q3 2017 Results …” on November 07, 2017. More interesting news about Tabula Rasa Healthcare, Inc. (NASDAQ:TRHC) were released by: Globenewswire.com and their article: “Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2016 Operating …” published on March 13, 2017 as well as Globenewswire.com‘s news article titled: “Tabula Rasa HealthCare Hosts 18 PACE Medical Directors at 2017 Annual Clinical …” with publication date: September 28, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: